Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Biome AustraliaASX:BIO +17.86%33 Debt-to-Equity is 0.40 as of Dec. 2025, which is 33% above its 10-year median of 0.30. GuruFocus rates ASX:BIO with a GF Score™ of 33/100 and a GF Value™ of A$0.69 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 1,752 Consumer Packaged Goods companies, Biome Australia ranks better than 52.05% on this metric.
A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.
The historical rank and industry rank for Biome Australia's Debt-to-Equity or its related term are showing as below:
ASX:BIO'
s Debt-to-Equity Range Over the Past 10 Years
Min: 0.01 Med: 0.3 Max: 0.68
Current: 0.4
During the past 5 years, the highest Debt-to-Equity Ratio of Biome Australia was 0.68. The lowest was 0.01. And the median was 0.30.
ASX:BIO's Debt-to-Equity is ranked better than 52.05% of 1752
companies
in the Consumer Packaged Goods industry
Industry Median: 0.42
vs ASX:BIO: 0.40
Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.
Biome Australia Debt-to-Equity Related Terms
Biome Australia Debt-to-Equity Historical Data
* Premium members only.
The historical data trend for Biome Australia's Debt-to-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Packaged Foods subindustry, Biome Australia's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Biome Australia Debt-to-Equity vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Biome Australia's Debt-to-Equity distribution charts can be found below:
* The bar in red indicates where Biome Australia's Debt-to-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Biome Australia (ASX:BIO) has a Debt-to-Equity of 0.40 as of Dec. 2025. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Biome Australia and its competitors. This is 33% above median its historical median of 0.30. Over the past decade, Biome Australia's Debt-to-Equity has ranged from 0.01 to 0.68. According to the industry distribution chart, Biome Australia ranks #840 out of 1752 companies in the Consumer Packaged Goods industry, placing it in the top 47.9%.
Is Biome Australia's Debt-to-Equity too high?
Biome Australia's current Debt-to-Equity of 0.40 is 33% above median its 10-year median of 0.30. Over the past 10 years, this metric has ranged from a low of 0.01 to a high of 0.68. The Consumer Packaged Goods industry median Debt-to-Equity is 0.42. Biome Australia's value of 0.40 is 4.8% below this industry median. Based on the distribution chart, Biome Australia ranks #840 out of 1752 companies in the Consumer Packaged Goods industry, which is above the industry midpoint. Overall, Biome Australia has a GF Score™ of 33/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Biome Australia's Debt-to-Equity compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, Biome Australia ranks #840 out of 1752 companies for Debt-to-Equity. This puts Biome Australia in the upper half of its industry. The industry median Debt-to-Equity is 0.42. Biome Australia's value of 0.40 is 4.8% below this benchmark. Historically, Biome Australia's own Debt-to-Equity has ranged from 0.01 to 0.68 over the past decade. While the company's 10-year median is 0.30 vs. the industry median of 0.42, Biome Australia has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Equity for a Consumer Packaged Goods company?
The median Debt-to-Equity among Consumer Packaged Goods companies is 0.42, based on 1,752 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-Equity significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Biome Australia's current Debt-to-Equity of 0.40 is 4.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Equity mean?
A high Debt-to-Equity can signal that a stock is expensive relative to its fundamentals. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Biome Australia and its competitors. For the Consumer Packaged Goods industry, the median Debt-to-Equity is 0.42 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Biome Australia's current Debt-to-Equity is 0.40, which is 33% above median its own 10-year median of 0.30. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biome Australia stock overvalued right now?
Based on GuruFocus' analysis, Biome Australia (ASX:BIO) is currently considered Possible Value Trap. The stock's GF Value™ is A$0.69, compared to a current price of A$0.33 — trading 52.2% below its estimated fair value. The current Debt-to-Equity is 0.40, which is 33% above median its 10-year median of 0.30 and 4.8% below the Consumer Packaged Goods industry median of 0.42. Biome Australia's overall GF Score™ is 33/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Equity calculated?
Debt-to-Equity is calculated from a company's financial statements. For Biome Australia (ASX:BIO), the current Debt-to-Equity is 0.40 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Biome Australia (ASX:BIO) Overvalued in 2026?
Based on GuruFocus' analysis, Biome Australia stock appears to be undervalued.
The current stock price of A$0.33 is trading 52.2% below its estimated GF Value™ of A$0.69.
GuruFocus considers Biome Australia to be Possible Value Trap.
Key valuation signals for ASX:BIO:
Debt-to-Equity: 0.40 (33% above median its 10-year median of 0.30)
GF Value™: A$0.69 vs. price of A$0.33 (52.2% below fair value)
Industry Position: 4.8% below the Consumer Packaged Goods median (#840 of 1752)
No single metric tells the full story. See the ASX:BIO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Biome Australia Ltd licences, develops, and markets evidence-based, complementary medicines, including nutraceuticals vitamins and weight management products and live biotherapeutics. The company has one operating segment: researching, developing, manufacturing and distributing evidence-based products linking the gut and human health. Domestically it caters to Australia and In international markets, the Group distributes and markets its Activated Probiotics range in the United Kingdom and New Zealand through independent health practitioners.
33GF Score
Get the complete analysis for ASX:BIO
Debt-to-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:BIO has been successfully added to your 
